Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Change in Cash (2016 - 2025)

Historic Change in Cash for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to -$1.9 million.

  • Kyntra Bio's Change in Cash rose 8078.47% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.0 million, marking a year-over-year decrease of 6336.51%. This contributed to the annual value of $50.5 million for FY2024, which is 3809.92% down from last year.
  • Per Kyntra Bio's latest filing, its Change in Cash stood at -$1.9 million for Q3 2025, which was up 8078.47% from $13.6 million recorded in Q2 2025.
  • Kyntra Bio's 5-year Change in Cash high stood at $116.3 million for Q4 2023, and its period low was -$244.9 million during Q1 2021.
  • In the last 5 years, Kyntra Bio's Change in Cash had a median value of -$8.0 million in 2024 and averaged -$19.7 million.
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 510367.62% in 2021, then surged by 4484576.92% in 2023.
  • Over the past 5 years, Kyntra Bio's Change in Cash (Quarter) stood at -$103.3 million in 2021, then soared by 99.75% to -$260000.0 in 2022, then skyrocketed by 44845.77% to $116.3 million in 2023, then crashed by 71.49% to $33.2 million in 2024, then tumbled by 105.63% to -$1.9 million in 2025.
  • Its Change in Cash was -$1.9 million in Q3 2025, compared to $13.6 million in Q2 2025 and $4.0 million in Q1 2025.